Nasdaq.comUS
bioAffinity Technologies, Inc. Reports Record Monthly Testing Volume in October 2026 for CyPath Lung
bioAffinity Technologies, Inc. announced that a record number of CyPath® Lung tests were performed in October 2026, marking the highest monthly testing volume for the noninvasive lung cancer…